An institutional export receivables financing initiative connecting Indian exporters with U.S. buyers, developed under Epiidosis Investments LLC (USA).
“Veltrix Global” is the current working name for this initiative; the venture’s permanent brand identity has not yet been finalized. This page describes the platform as it exists today and will be updated as the venture and its branding develop.
| Working Name | Veltrix Global |
|---|---|
| Parent Entity | Epiidosis Investments LLC (USA) |
| Jurisdiction | Delaware, United States |
| Corridor | India → United States |
| Status | Platform in development; live technology and operations layer, early counterparty engagement |
The platform purchases, on a non-recourse basis, accepted invoices owed to Indian exporters by U.S. buyers — providing exporters with an immediate cash advance against those receivables rather than waiting out standard payment terms. Structured as a sale of receivables rather than a loan, with full risk transfer to the purchasing entity upon acceptance.
| Advance Rate | Up to 85% loan-to-value against the accepted invoice |
|---|---|
| Execution Time | Typically within 48 hours of acceptance |
| Discount | Approximately 1.5% per 30 days |
| Reserve | Approximately 13.5% held until invoice maturity |
Figures above are indicative of current platform terms and are subject to change as the venture develops. They do not constitute a committed offer.
Exporters, U.S. buyers, and institutional finance partners interested in this initiative are invited to make contact through Epiidosis Investments LLC (USA).